Brewin Dolphin LTD Denali Therapeutics Inc. Transaction History

Brewin Dolphin LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2023	SELL	$48.48 - $78.23 $2,424 - $3,911	-50 Reduced 10.0%	450 $22.7 Million
Q3 2019 Nov 09, 2023	SELL	$15.32 - $21.92 $3,293 - $4,712	-215 Reduced 30.07%	500 $7.66 Million
Q1 2019 Nov 09, 2023	BUY	$17.99 - $24.65 $11,063 - $15,159	615 Added 615.0%	715 $16.6 Million
Q2 2018 Nov 09, 2023	BUY	$15.25 - $21.02 $1,525 - $2,102	100 New	100 $1.53 Million

240

111M

80K

36.8K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.78B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.